Literature DB >> 1559228

Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes.

B Y Li1, D Mohanraj, M C Olson, M Moradi, L Twiggs, L F Carson, S Ramakrishnan.   

Abstract

Ascitic fluid from human ovarian cancer patients often contains a large number of leukocytes along with tumor cells. Some of the recent evidence suggests that the ascitic fluid contains factors capable of inducing the growth of ovarian cancer cells in vitro and in vivo. While these factors have not yet been completely characterized, growth factors secreted by the tumor cells could influence the tumor growth by paracrine and autocrine mechanisms. Earlier, we reported that ovarian epithelial cancer cells produce macrophage colony-stimulating factor. It appears that these tumor cells produce more than one cytokine. Identifying the various products secreted by the tumor cells would provide valuable information needed to understand the biology of ovarian cancer. In the present study, evidence is provided for the first time that five different human ovarian epithelial tumor cell lines and tumor cells isolated from the ascitic fluid of four cancer patients express interleukin (IL) 1 alpha and beta genes constitutively. Production of the lymphokine was determined by analyzing the cellular RNA for IL-1-related transcripts and by immunological assays. Ovarian cancer cells also secrete another pleiotropic cytokine, IL-6, constitutively. In many systems, IL-1 induces the expression of the IL-6 gene. To determine whether the basal levels of IL-6 production are dependent on the endogenous IL-1, neutralization studies were carried out. Addition of antibodies to IL-1 did not decrease the levels of IL-6 secreted by the cancer cell lines. These results suggest that multiple cytokines are produced by ovarian cancer cells and that the endogenous IL-1 may not be directly involved in the regulation of IL-6 gene expression in these cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559228

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors:  Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-28       Impact factor: 4.234

2.  Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.

Authors:  Shintaro Nakao; Takashi Kuwano; Chikako Tsutsumi-Miyahara; Shu-ichi Ueda; Yusuke N Kimura; Shinjiro Hamano; Koh-hei Sonoda; Yasuo Saijo; Toshihiro Nukiwa; Robert M Strieter; Tatsuro Ishibashi; Michihiko Kuwano; Mayumi Ono
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

3.  Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1.

Authors:  F A Offner; H Feichtinger; S Stadlmann; P Obrist; C Marth; P Klingler; B Grage; M Schmahl; C Knabbe
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.

Authors:  G Mantovani; A Macciò; R Versace; M Pisano; P Lai; S Esu; M Ghiani; D Dessì; E Turnu; M C Santona
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

5.  The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese population.

Authors:  Xue Qin; Qiliu Peng; Xiaoxia Lao; Zhiping Chen; Yu Lu; Xianjun Lao; Cuiju Mo; Jingzhe Sui; Junrong Wu; Limin Zhai; Shi Yang; Shan Li; Jinmin Zhao
Journal:  Tumour Biol       Date:  2013-10-08

6.  Growth inhibition of human gastrointestinal cancer cells by cyclosporin A.

Authors:  M Piontek; R Porschen
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

7.  Involvement of hepatocyte growth factor in increased integrin expression on HepG2 cells triggered by adhesion to endothelial cells.

Authors:  N Kawakami-Kimura; T Narita; K Ohmori; T Yoneda; K Matsumoto; T Nakamura; R Kannagi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  IL-1α -889 C/T polymorphism and cancer susceptibility: a meta-analysis.

Authors:  Daye Cheng; Yiwen Hao; Wenling Zhou
Journal:  Onco Targets Ther       Date:  2014-11-10       Impact factor: 4.147

Review 9.  Ovarian cancer: pathology, biology, and disease models.

Authors:  Daniel G Rosen; Gong Yang; Guangzhi Liu; Imelda Mercado-Uribe; Bin Chang; Xue Sherry Xiao; Jingfang Zheng; Feng-Xia Xue; Jinsong Liu
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene.

Authors:  G Krupitza; R Fritsche; E Dittrich; H Harant; H Huber; T Grunt; C Dittrich
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.